Decline in breast cancer cases likely linked to reduced Use of hormone replacement.
Ads by Google
Genomic tests are developed to better predict how breast cancer patients will respond to chemotherapy or hormonal therapy.
The widely used breast cancer drug tamoxifen (Nolvadex), which can become less effective over time, might retain its full strength indefinitely if used along with a second drug.
Viewing prior mammograms in association with current mammograms significantly improves radiologist performance in detecting breast cancer.
FDA has granted an expanded clearance for the CellSearch System to be used as an aid in the monitoring of metastatic breast cancer.
Test provides surgeon with real time information that may aid breast cancer treatment decisions.
Reducing dietary fat intake may decrease the chance of a breast cancer recurrence in women who have been treated for early-stage breast cancer.
Postmenopausal women with early stage, hormone sensitive breast cancer have a lower risk of disease recurrence when their treatment includes a new class of hormone therapy drugs.
Higher physical activity is associated with reduced risk of breast cancer.
The experimental biological agent, lapatinib, successfully and specifically treats inflammatory breast cancer.
Breast cancer incidence in the United States dropped sharply, and this decline may largely be due to the fact that millions of older women stopped using hormone replacement therapy
Addition of Fuji CR Mammography Technology to Siemens' portfolio provides facilities with options for breast cancer screening.
Giving radiation therapy and chemotherapy at the same time after a lumpectomy helps keep breast cancer from returning locally
Introducing a more potent form of a family of drugs called bisphosphonates to breast cancer patients with bone disease progression improves their quality of life.
A decreased risk of breast cancer is associated with consuming soy during childhood, adolescence and adult life.
FDA expands the use of Herceptin, a Genentech breast cancer drug, for early stage breast cancer treatment after primary therapy.
A higher risk for hormone receptor positive breast cancers in premenopausal women is linked to eating more red meat.
Many newly diagnosed breast cancer patients have unrecognized and undertreated psychological needs.
The prognosis of an individual with breast cancer can be predicted by the activity of a gene that commandeers other cancer causing genes, returning them to normal.
For women who have had surgery for early breast cancer, it may not matter whether they receive follow up chemotherapy before, after or during radiation therapy.
Research linking Ashkenazi Jews and breast cancer genes beset by problems, leads to health disparities.
Black women with breast cancer were more likely to have larger, later stage tumors that were more difficult to treat and also had lower survival rates than Hispanic and Caucasian women who received the same treatment.
The number of older breast cancer patients has increased along with overall elderly population and elderly patients with breast cancer may have been under diagnosed, under staged and under treated.
More women survive breast cancer, but the rates continue to rise according to the latest report from the National Breast Cancer Centre (NBCC) and the Australian Institute of Health and Welfare (AIHW).
Findings may lead to new ways to detect and destroy cells before they become cancerous.
28 percent of the breast cancer patients stated they were dissatisfied with the cosmetic result of their lumpectomy.
Women undergoing radiation treatment for breast cancer benefit from moderate intensity, regular aerobic activity.